利用CT血管造影中血管周围脂肪组织衰减评估腹主动脉瘤进展
这项多中心回顾性研究纳入167例腹主动脉瘤患者,在基线CTA上测量血管周围脂肪组织衰减,分为高衰减(>-73.4 HU)与低衰减(≤-73.4 HU)。中位随访11.3个月期间67例(40.1%)出现腹主动脉瘤进展,多变量Cox回归显示高基线PVAT衰减与腹主动脉瘤进展独立相关(aHR=2.23;95%CI 1.16-4.32;P=0.017),在伴附壁血栓亚组中结果一致(aHR=2.23;95%CI 1.08-4.60;P=0.030)。
要点
- 基线PVAT衰减高(>-73.4 HU)与腹主动脉瘤进展独立相关(aHR=2.23;95%CI 1.16-4.32;P=0.017)。
- 在伴附壁血栓的腹主动脉瘤患者中,高基线PVAT衰减同样独立相关(aHR=2.23;95%CI 1.08-4.60;P=0.030)。
- 腹主动脉瘤进展定义为随访期间动脉瘤体积较基线增加>10 mL,167例中67例(40.1%)出现进展。
核心结论
- 升高的血管周围脂肪组织衰减与腹主动脉瘤进展独立相关,包括伴附壁血栓的腹主动脉瘤患者,提示PVAT衰减可能作为腹主动脉瘤扩张的预测影像标志物。
研究设计与样本
- 多中心回顾性研究,纳入2015年3月至2022年7月期间在基线和随访时接受CTA的腹主动脉瘤患者167例(男性148例;中位年龄70.0岁;四分位距63.0-76.0岁),其中145例(86.8%)伴有附壁血栓。
关键影像表现/征象
- 基线CTA测量腹主动脉瘤最大直径和总体积、附壁血栓是否存在及其最大直径和体积,以及动脉瘤的PVAT衰减。
- PVAT衰减分为高衰减(>-73.4 HU)和低衰减(≤-73.4 HU)。
诊断标准与关键数值
- 腹主动脉瘤进展定义为随访期间动脉瘤体积较基线增加>10 mL。
- 高基线PVAT衰减(>-73.4 HU)与腹主动脉瘤进展独立相关:aHR=2.23;95%CI 1.16-4.32;P=0.017。
- 在伴附壁血栓的腹主动脉瘤亚组中,高基线PVAT衰减(>-73.4 HU)与腹主动脉瘤进展独立相关:aHR=2.23;95%CI 1.08-4.60;P=0.030。
临床应用与阅片要点
- 基线CTA上可测量腹主动脉瘤的PVAT衰减,以>-73.4 HU作为高衰减界值,该指标与随访期间动脉瘤体积增加>10 mL独立相关。
- 对于伴有附壁血栓的腹主动脉瘤患者,基线PVAT衰减>-73.4 HU同样与动脉瘤进展独立相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Recent studies have highlighted the active and potential role of perivascular adipose tissue (PVAT) in atherosclerosis and aneurysm progression, respectively. This study explored the link between PVAT attenuation and abdominal aortic aneurysm (AAA) progression using computed tomography angiography (CTA).
MATERIALS AND METHODS: This multicenter retrospective study analyzed patients with AAA who underwent CTA at baseline and follow-up between March 2015 and July 2022. The following parameters were obtained: maximum diameter and total volume of the AAA, presence or absence of intraluminal thrombus (ILT), maximum diameter and volume of the ILT, and PVAT attenuation of the aortic aneurysm at baseline CTA. PVAT attenuation was divided into high (> -73.4 Hounsfield units [HU]) and low (≤ -73.4 HU). Patients who had or did not have AAA progression during the follow-up, defined as an increase in the aneurysm volume > 10 mL from baseline, were identified. Kaplan-Meier and multivariable Cox regression analyses were used to investigate the association between PVAT attenuation and AAA progression.
RESULTS: Our study included 167 participants (148 males; median age: 70.0 years; interquartile range: 63.0-76.0 years), of which 145 (86.8%) were diagnosed with AAA accompanied by ILT. Over a median period of 11.3 months (range: 6.0-85.0 months), AAA progression was observed in 67 patients (40.1%). Multivariable Cox regression analysis indicated that high baseline PVAT attenuation (adjusted hazard ratio [aHR] = 2.23; 95% confidence interval [CI], 1.16-4.32; P = 0.017) was independently associated with AAA progression. This association was demonstrated within the patients of AAA with ILT subcohort, where a high baseline PVAT attenuation (aHR = 2.23; 95% CI, 1.08-4.60; P = 0.030) was consistently independently associated with AAA progression.
CONCLUSION: Elevated PVAT attenuation is independently associated with AAA progression, including patients of AAA with ILT, suggesting the potential of PVAT attenuation as a predictive imaging marker for AAA expansion.
引用
- Zhang S, Gu H, Chang N, et al. Assessing Abdominal Aortic Aneurysm Progression by Using Perivascular Adipose Tissue Attenuation on Computed Tomography Angiography. Korean J Radiol. 2023. PMID: 37724591. doi:10.3348/kjr.2023.0339
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。